<DOC>
	<DOC>NCT01683760</DOC>
	<brief_summary>The purpose of this study is to investigate the pharmacokinetics of fluconazole which is used as prophylaxis of invasive fungal infection in premature infants.</brief_summary>
	<brief_title>Pharmacokinetic Study of Fluconazole in Premature Infants</brief_title>
	<detailed_description />
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>very low birth weight infant (birth weight &lt; 1,500 g) who were admitted to the NICU before day 3 of life Informed consent from the parents Major congenital anomaly Expired within 72 hours of life Liver failure (AST or ALT levels with three times the upper limit of the range of normal values or higher) Proven congenital or intrauterine fungal infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Fluconazole</keyword>
</DOC>